Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Joint
Meeting of the Peripheral and Central Nervous System Drugs Advisory
Committee and the Center for Devices and Radiological Health (CDRH)
Dental Products Panel
September 6-7, 2006
Larry Goldstein, M.D
• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)
Sandra Olson, M.D.
• 18 U.S.C. 208 waiver (pdf)
• Acknowledgement and Consent (pdf)
Page updated:
August 1, 2006
|